{"count": 4, "results": [{"_id": "34803924", "pmid": 34803924, "pmcid": "PMC8595278", "title": "Oral Antidiabetics and Sleep Among Type 2 Diabetes Patients: Data From the UK Biobank", "journal": "Front Endocrinol (Lausanne)", "authors": ["Xue P", "Wu J", "Tang X", "Tan X", "Benedict C"], "date": "2021-11-03T00:00:00Z", "doi": "10.3389/fendo.2021.763138", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "763138", "score": 50253.984, "text_hl": "As shown by logistic regression adjusted for, e.g., age, @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ duration, and HbA1c, @SPECIES_9606 @@@patients@@@ on non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy (N=815; 86% were treated with @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonylureas@@@) had a 1.24-fold higher odds ratio of reporting regular @<m>DISEASE_Ocular_Albinism_type_1</m> @DISEASE_MESH:C537863 @@@difficulty falling and staying asleep@@@ at night compared to those without antidiabetic medication use (N=5 366, P<0.05) or those on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy (N=5 625, P<0.05). ", "citations": {"NLM": "Xue P, Wu J, Tang X, Tan X, Benedict C. Oral Antidiabetics and Sleep Among Type 2 Diabetes Patients: Data From the UK Biobank Front Endocrinol (Lausanne). 2021;12():763138. PMID: 34803924", "BibTeX": "@article{34803924, title={Oral Antidiabetics and Sleep Among Type 2 Diabetes Patients: Data From the UK Biobank}, author={Xue P and Wu J and Tang X and Tan X and Benedict C}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={763138}}"}}, {"_id": "20215495", "pmid": 20215495, "title": "Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly.", "journal": "Ann Pharmacother", "authors": ["Berlie HD", "Garwood CL"], "date": "2010-04-01T00:00:00Z", "doi": "10.1345/aph.1M551", "meta_date_publication": "2010 Apr", "meta_volume": "44", "meta_issue": "4", "meta_pages": "712-7", "score": 50059.758, "text_hl": "Selection emphasis was placed on randomized studies evaluating @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes medications@@@ and @<m>DISEASE_Ocular_Albinism_type_1</m> @DISEASE_MESH:C537863 @@@falls@@@. DATA SYNTHESIS: There is no direct link between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>DISEASE_Ocular_Albinism_type_1</m> @DISEASE_MESH:C537863 @@@falls@@@; however, an indirect association caused by @DISEASE_Nervous_System_Diseases @DISEASE_MESH:D009422 @@@neuropathy@@@ secondary to @DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@vitamin B(12) deficiency@@@ may be of concern. ", "citations": {"NLM": "Berlie HD, Garwood CL. Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly. Ann Pharmacother. 2010 Apr;44(4):712-7. PMID: 20215495", "BibTeX": "@article{20215495, title={Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly.}, author={Berlie HD and Garwood CL}, journal={Ann Pharmacother}, volume={44}, number={4}, pages={712-7}}"}}, {"_id": "31250977", "pmid": 31250977, "title": "The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies.", "journal": "Obes Rev", "authors": ["Hidayat K", "Du X", "Wu MJ", "Shi BM"], "date": "2019-10-01T00:00:00Z", "doi": "10.1111/obr.12885", "meta_date_publication": "2019 Oct", "meta_volume": "20", "meta_issue": "10", "meta_pages": "1494-1503", "score": 50039.89, "text_hl": "The use of @GENE_INS @GENE_3630 @@@insulin@@@ or @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonylureas@@@ may increase @DISEASE_Fractures_Bone @DISEASE_MESH:D050723 @@@fracture@@@ risk; this risk is most likely attributed to an increased risk of hypoglycaemia-induced @<m>DISEASE_Ocular_Albinism_type_1</m> @DISEASE_MESH:C537863 @@@falls@@@. Further confirmation by additional RCTs is required to determine whether the observed association between the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @GENE_INS @GENE_3630 @@@insulin@@@, or @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonylureas@@@ and the risk of @DISEASE_Fractures_Bone @DISEASE_MESH:D050723 @@@fracture@@@ is due to treatment with these medications or confounding factors.", "citations": {"NLM": "Hidayat K, Du X, Wu MJ, Shi BM. The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies. Obes Rev. 2019 Oct;20(10):1494-1503. PMID: 31250977", "BibTeX": "@article{31250977, title={The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies.}, author={Hidayat K and Du X and Wu MJ and Shi BM}, journal={Obes Rev}, volume={20}, number={10}, pages={1494-1503}}"}}, {"_id": "28938433", "pmid": 28938433, "title": "Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management.", "journal": "J Clin Endocrinol Metab", "authors": ["Paschou SA", "Dede AD", "Anagnostis PG", "Vryonidou A", "Morganstein D", "Goulis DG"], "date": "2017-10-01T00:00:00Z", "doi": "10.1210/jc.2017-00042", "meta_date_publication": "2017 Oct 1", "meta_volume": "102", "meta_issue": "10", "meta_pages": "3621-3634", "score": 50029.676, "text_hl": "Healthy diet and physical exercise are very important for the prevention and treatment of both entities. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@, dipeptidyl peptidase-4 inhibitors, and @GENE_GLP1R @GENE_2740 @@@glucagon-like peptide-1 receptor@@@ agonists should be preferred for the treatment of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ in these @SPECIES_9606 @@@patients@@@, whereas strict targets should be avoided for the fear of @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@hypoglycemia@@@, @<m>DISEASE_Ocular_Albinism_type_1</m> @DISEASE_MESH:C537863 @@@falls@@@, and @DISEASE_Fractures_Bone @DISEASE_MESH:D050723 @@@fractures@@@. ", "citations": {"NLM": "Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management. J Clin Endocrinol Metab. 2017 Oct 1;102(10):3621-3634. PMID: 28938433", "BibTeX": "@article{28938433, title={Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management.}, author={Paschou SA and Dede AD and Anagnostis PG and Vryonidou A and Morganstein D and Goulis DG}, journal={J Clin Endocrinol Metab}, volume={102}, number={10}, pages={3621-3634}}"}}]}